Sana Biotechnology files to go public, looks to cure disease by modifying genes in the body

Retrieved on: 2021-01-13 16:25:34

Tags for this article:

Click the tags to see associated articles and topics

Sana Biotechnology files to go public, looks to cure disease by modifying genes in the body. View article details on hiswai:

Excerpt

CEO Steve Harr, the 50-year-old former CFO at Juno, holds a 5.6% stake. And like many biotechnology companies it is losing money. It had ...

Article found on: www.geekwire.com